[Skip to Content]
[Skip to Content Landing]
Controversies in Neurology
May 2003

Resolved: NASCET and ACAS Need Not Be Repeated: The Affirmative Position

Author Affiliations

From the Division of Vascular Surgery, Geffen School of Medicine, University of California Los–Angeles.

 

STEVEN T.DEKOSKYMD

Arch Neurol. 2003;60(5):775-778. doi:10.1001/archneur.60.5.775

THE NASCET1 and the ACAS2 were the largest and best-organized trials affecting the management of extracranial carotid arteriosclerosis. Both trials have clearly defined patient populations that benefit from carotid endarterectomy compared with best medical management.

×